Download Files:
Cilazapril (monohydrate)
SKU
HY-A0043A-10 mg
Category Reference compound
Tags Angiotensin-converting Enzyme (ACE), Cardiovascular Disease, Metabolic Enzyme/Protease
$780 – $6,200
Web ID
– HY-A0043A
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C22H33N3O6
References
– [1]Szucs, T., Cilazapril. A review. Drugs, 1991. 41 Suppl 1: p. 18-24.|[2]Nussberger, J., et al., Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol, 1987. 9(1): p. 39-44.
CAS Number
– 92077-78-6
Molecular Weight
– 435.51
Compound Purity
– 99.94
SMILES
– O=C([C@@H]1CCCN2N1C([C@@H](N[C@H](C(OCC)=O)CCC3=CC=CC=C3)CCC2)=O)O.O
Clinical Information
– Launched
Research Area
– Cardiovascular Disease
Solubility
– 0.1 M NaOH : 14.29 mg/mL (ultrasonic;warming;adjust pH to 10 with NaOH;heat to 60°C)|DMSO : ≥ 100 mg/mL
Target
– Angiotensin-converting Enzyme (ACE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.